+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiological effects of the tricyclic antidepressant desipramine on mammalian myocardium

Biomedica Biochimica Acta 43(7): 1005-1016
Electrophysiological effects of the tricyclic antidepressant desipramine on mammalian myocardium
Effects of desipramine (DPr), a tricyclic antidepressant, on isolated trabeculae of the right rabbit atrial myocardium were studied using a standard microelectrode technique. Between 10(-7) and 10(-4) g/ml DPr reduced the maximum upstroke velocity Vmax of the action potentials. The membrane responsiveness was found to be depressed for DPr increased the time constant of the recovery of Vmax in a concentration-dependent manner distinctly. The voltage-Vmax relationships were shifted to more positive potentials and were flattend by increasing the concentration of DPr. DPr prolonged the duration of the action potentials on all levels of repolarization. Between 10(-7) and 10(-5) g/ml both resting and overshoot potential were found to be unchanged. At concentrations higher than 10(-5) g/ml slow response action potential insensitive to 10(-5) mol/l TTX were evoked, the resting transmembrane potential depolarized, spatial inhomogeneities in transmembrane potential and triggered activity could be observed. DPr may act antiarrhythmogenically in a quinidine-like manner at concentrations between 10(-7) and 10(-5) g/ml by (1) decreasing the fast channel conductance, (2) delaying the recovery of the fast channel. At concentrations higher than 10(-5) g/ml DPr could effect arrhythmogenic actions by a complete depression of fast response action potentials, unmasking of slow response action potentials and generation of severe spatial inhomogeneities.

Accession: 005349603

PMID: 6517884

Related references

Actions of lofepramine, a new tricyclic antidepressant, and desipramine on electrophysiological and mechanical parameters of guinea pig atrial and papillary muscles. Acta Pharmacologica et Toxicologica 49(4): 248-258, 1981

The tricyclic antidepressant desipramine has biphasic effects on the growth of rat pheochromocytoma pc12 cells in vitro. Society for Neuroscience Abstracts 15(1): 851, 1989

Inhibitory actions of amoxapine a tricyclic antidepressant agent on electrophysiological properties of mammalian isolated cardiac preparations. British Journal of Pharmacology 94(4): 1250-1256, 1988

Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats. Journal of Pharmacology and Experimental Therapeutics 321(2): 770-776, 2007

Electrophysiological methods in assessing cardiac effects of the tricyclic antidepressant imipramine. Acta Medica Scandinavica 203(5): 429-432, 1978

The effects of a potential antidepressant, 2,4-dimethyl-5-(3-fluorophenyl)-3H-1,2,4-triazole-3-thione, in an electrophysiological model responsive to desipramine. Neuropharmacology 29(6): 555-560, 1990

Effects of tricyclic antidepressant drugs on the electrophysiological properties of drug Purkinje fibers. Journal of Cardiovascular Pharmacology 4(1): 82-90, 1982

Comparison of FT-IR and AAS for metalloimmunoassay of a tricyclic antidepressant drug (desipramine). Journal of Pharmaceutical and Biomedical Analysis 8(8-12): 979-982, 1990

Modulation of adrenergic expression by the tricyclic antidepressant desipramine dmi. Society for Neuroscience Abstracts 15(2): 1017, 1989

The tricyclic antidepressant desipramine inhibits T3 import into primary neurons. Neuroscience Letters 478(1): 5-8, 2010